AwardTape · Defense awards · Novartis Pharmaceuticals Corporation
Novartis Pharmaceuticals Corporation: $8.1M in DoD and DHS awards (this registration)
This registration, Novartis Pharmaceuticals Corporation, holds 8 DoD and DHS prime awards with $8.1M obligated Sep 18, 2024 to Feb 11, 2026. Largest category: Drugs and biologicals at $7.1M; largest buyer: Department of the Army at $6.6M.
| Obligated FY2024+ | $8.1M |
|---|---|
| Awards | 8 |
| FY2024 | $0 |
| FY2025 | $3.8M |
| FY2026 to date | $4.3M |
| Lifetime obligated on these awards | $8.1M |
| Parent company | Novartis: $12.3M in DoD and DHS awards since FY2024 across 2 registrations |
| First and latest action | Sep 18, 2024 · Feb 11, 2026 |
| # | Category | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Drugs and biologicals | $7.1M | 6 awards | 88% |
| 2 | Diagnostics and lab supplies | $981K | 2 awards | 12% |
| # | Agency | Obligated FY2024+ | Awards | Share |
|---|---|---|---|---|
| 1 | Department of the Army | $6.6M | 3 awards | 82% |
| 2 | Defense Health Agency | $1.5M | 5 awards | 18% |
| Award | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|
| W81K0024F0177 delivery order | $3.4M | Delivery order for pluvicto and lutathera | Army | Drugs and biologicals | Jul 1, 2025 DoD 90d |
| W81K0025FA195 delivery order | $3.2M | Lutathera and pluvicto | Army | Drugs and biologicals | Jan 30, 2026 DoD 90d |
| HT001426PE027 purchase order | $579K | Acquisition of pluvicto and lutathera for radiology patients. | Defense Health Agency | Diagnostics and lab supplies | Jan 12, 2026 DoD 90d |
| HT001425PE011 purchase order | $403K | Service maintenance for dental compressor located at dilorenzo tricare health clinic | Defense Health Agency | Diagnostics and lab supplies | Sep 8, 2025 DoD 90d |
| HT941026FE013 delivery order | $276K | Pluvicto and lutathera injections | Defense Health Agency | Drugs and biologicals | Dec 19, 2025 DoD 90d |
| HT941026FE027 BPA call | $206K | Pluvicto and lutathera injection | Defense Health Agency | Drugs and biologicals | Feb 11, 2026 DoD 90d |
| HT941026AE002 blanket purchase agreement | $0 | Bpa for pluvicto and lutathera injection | Defense Health Agency | Drugs and biologicals | Feb 9, 2026 DoD 90d |
| W81K0024D0004 IDIQ contract | $0 | Idiq for cancer therapy drugs: lutathera and pluvicto | Army | Drugs and biologicals | Jan 8, 2026 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters, alerts and CSV export for this company's awards.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial